The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Relationship between OS and PFS in metastatic breast cancer (MBC): Review of FDA submission data.
P. Cortazar
No relevant relationships to disclose
J. J. Zhang
No relevant relationships to disclose
R. Sridhara
No relevant relationships to disclose
R. L. Justice
No relevant relationships to disclose
R. Pazdur
No relevant relationships to disclose